EVERYTHING ABOUT MCC950 SDS

expression, which is a key driver of NIH. Within an in vivo mouse model of NIH in vascular grafts, MCC950 significantly Improved re‐endothelialization and lowered NIH in comparison with PTX or SMS.These conclusions demonstrate the performance of the specific anti‐inflammatory drug‐elution technique with substantial implications for cardiovasc